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Abstract
Trimers of the HIV-1 envelope glycoprotein (Env) effectuate viral entry into susceptible cells. Therefore Env trimers are the targets for
neutralizing antibodies. This study models the number of trimers required for virion infectivity. It also delineates the minimum number of antibody
molecules that would neutralize a virion. First, Env function was assumed to be incremental (all envelope glycoprotein units contribute equally) or
liminal (characterized by thresholds). Then, such models were combined and shown to fit published data on phenotypically mixed pseudotype
viruses. Virions with 9 trimers would require around a median of 5 of them for strong infectivity; the proportion varies among strains and mutants. In
addition, the models account for both liminal and incremental protomeric effects at the trimer level: different inert Env mutants may affect trimer
function in different degrees. Because of compensatory effects at the virion and trimer levels, however, current data cannot differentiate between all
plausible models. But the biophysically and mathematically rationalized blurring of thresholds yields candidate models that fit different data
excellently.
© 2007 Elsevier Inc. All rights reserved.Keywords: HIV-1; Entry; Envelope glycoprotein; Trimer; Phenotypic mixing; Neutralization; Molecularity; OccupancyIntroduction
How many envelope glycoprotein (Env) molecules does it
take to render an HIV-1 particle infectious? The answer would
inform anti-viral strategies.
HIV-1 Env consists of a surface moiety, SU, and a trans-
membrane protein, TM. These subunits form non-covalent
hetero-dimers. Trimers of such hetero-dimers stud the virion. At
the start of an infectious cycle, the trimers bind to the main
receptor for the virus, CD4, on the target cell surface. This
binding induces conformational changes in the Env oligomer
that promote interactions with a coreceptor, CCR5 or CXCR4
(for reviews, see Moore and Doms, 2003; Poignard et al., 2001).
Then, as a consequence of these interactions, TM refolds into a
coiled coil that fuses the viral and cellular membranes (Chan
et al., 1997; Gallo et al., 2003; Matthews et al., 2004;Abbreviations: HIV, human immunodeficiency virus; SIV, Simian immu-
nodeficiency virus; Ab, antibody; NAb, neutralizing antibody; Env, envelope
glycoprotein; PI, primary isolate; TCLA, T-cell line-adapted strain.
⁎ Fax: +1 212 746 8340.
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doi:10.1016/j.virol.2007.06.044Weissenhorn et al., 1997). Because of these functions, Env is
the target for neutralizing antibodies (NAbs) (Poignard et al.,
2001; Wyatt and Sodroski, 1998).
A specific tool now aids the quantitative analysis of Env-
mediated entry: cells are transfected with genes for functional
and defective forms of Env. Mixed trimers form in these cells
and are eventually incorporated into virions. The infectivity of
the resulting virus can be analyzed with combinatorial models.
Analogously, one can model the infectivity of virus containing
different proportions of antigenic and non-antigenic Env in the
presence of an excess of NAbs. Such modeling has suggested
that all three subunits must be unencumbered for the Env trimer
to function (Herrera et al., 2006; Iwatani et al., 2001; Schonning
et al., 1999; Yang et al., 2005a,b).
Yang et al. (2005a,b) drew further conclusions: that a single
trimer is capable of mediating the infectivity of a virion; that
therefore neutralization requires the occupancy of all functional
trimers by NAbs. A single trimer per virion was also deemed
sufficient for the infectivity of other retroviruses: amphotropic
murine leukemia virus (A-MLV) and avian sarcoma/leucosis
virus type A (ASLA-A) (Yang et al., 2005b). The authors
furthermore posited that HIV-1 virions have only the bare
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They inferred this from the low ratio of infectious to total number
of particles for HIV (ranging from ∼10− 2 to ∼10− 5)
(Bourinbaiar, 1994; Dimitrov et al., 1993; Klasse and McKeat-
ing, 1993; Layne et al., 1992). On this view, retroviral particles
usually only have a single functional trimer, which is exactly
what they require for entry into target cells.
More recently, Yang et al. (2006a) analyzed the effects on
infectivity of incorporating Env with mutations in the CD4-
binding site, in the chemokine-receptor-binding site or in the
fusion segment of TM. Again, they came to the conclusion that a
single trimer mediates the infectivity of a virion. But they
concluded that with these Env defects, a trimer can tolerate one
mutant protomer and still have intact function.
The following mathematical modeling delineates alternative
hypotheses. In order to model, we must make assumptions about
Env and virions. First, we must explore how the three subunits in
a trimermay contribute to its function. Secondly, wemust assume
that virions have a certain number of trimers, e.g., about 9–14
(Zhu et al., 2003; Zhu et al., 2006) or a wider range. Thirdly,
we must ask how many trimers are required for infectivity.
In order to analyze the number of NAbs per virion involved
in neutralization, a previous framework postulated thresholds
above which the virions are inactivated (Klasse and Moore,
1996). An empirical study of neutralization was unable to refute
such thresholds (Schonning et al., 1999). As a viable alternative,
however, that study promulgated proportionally incremental
effects of the binding of NAbs to Env. The data thus sustained
principally different hypotheses of how infectivity varied with
the amount of NAb bound.
In the current modeling, these two accounts of infectivity are
explored further. On the one hand there is the possibility of
thresholds, or liminal effects: the infectivity of a virion depends
on a critical number of functional trimers, below which it is
completely inert. On the other hand, there may be incremental
effects: each Env unit contributes independently to the
infectivity of a virion. It makes biological sense to blend these
two accounts. What is more, the resulting mixed models closely
fit distinct sets of data on phenotypically mixed pseudotype
virus. Several of the best fitting models suggest that different
virions need around half of their trimers for strong infectivity.
But this modeling remains tentative for several reasons. The
premises cannot yet be anchored in definitive knowledge about
infectious virions. The problems are complex and the data scant
and imprecise. Numerous variants of principally distinct models
can be derived. Some mathematical functions can have more
than one biological interpretation. Rivaling models may be
empirically indistinguishable. Nevertheless, published data
refute vast arrays of models.
Results
The modeling was performed in five steps:
1. The mathematical models of Env function were derived.
These apply to virions with randomly mixed active and inert
Env protomers. Combinatorial analysis was applied at twolevels, the trimer and the virion. This yielded a basic frame-
work for liminal and incremental models.
2. The available data on phenotypically mixed virus (Herrera et
al., 2006; Yang et al., 2005a,b; Yang et al., 2006a) were
contrasted with the basic liminal and incremental models. The
models generally diverged substantially from the data.
3. As a prelude to optimal model design, the proximity of the
data to an incremental extreme or a liminal alternative was
explored. For the latter, the number of trimers per virion, as
well as the number of trimers at the threshold of inhibition,
was varied. Some mixed models along the spectra fit better
than pure ones.
4. Virion heterogeneity and incremental effects were taken into
account by allotting differential, gradual weights to thresh-
olds. Such softening of the thresholds brought the models
closer to the data.
5. Incremental effects were allowed also at the trimer level. The
resulting mixed liminal–incremental models suggested vari-
able effects on trimer function among mutants. Nevertheless,
the first inert protomer in a trimer maintained a strong effect in
different models that best fit all the data sets.
The basic models of infectivity as a function of active Env
The infectivity of phenotypically mixed virions is normalized
against that of virions with purely functional Env protomers. The
models express the relative infectivity, I, on the y axis and the
proportion of functional Env protomers, p, on the x axis (see
Table 1 for all symbols).
S is the minimal number of non-functional protomers
required to inactivate a trimer (Fig. 1A). S=1 means that a
single non-functional Env protomer renders the whole trimer
inert. Then the functional fraction of trimers, q, is p3.
For S=2, the fraction of functional trimers is q=3p2−2p3.
For S=3, q=3p−3p2 +p3 (see Fig. 1A for illustration and
Methods for derivations).
The goal is a general framework for the analysis of HIV-1
with randomly mixed functional and non-functional Env
protomers. Here “functional” can mean different things. It can
be the absence of mutations that abrogate the Env-mediated
entry process. Conversely, when neutralization is modeled,
“non-functional Env” means wild-type Env that is completely
occupied by a NAb present in excess (Fig. 1B). It also deserves
emphasis that randomness, or independence, of the individual
combinatorial events, is a central premise when the binomial
theorem is applied. Any deviation from independence invali-
dates the straightforward interpretation of the best fits of
binomial-derived functions. There are strong indications that
different versions of HIV Env protomers do hetero-trimerize: the
dominant-negative effect of defective Env is best explained if
wild-type and defective Env hetero-trimerize (Iwatani et al.,
2001; Yang et al., 2005b). Immunoprecipitations indicate that
hetero-trimers form in cells co-transfected with two forms of
Env (Salzwedel and Berger, 2000), although it cannot be entirely
ruled out that contiguous trimers that have co-localized to
imperfectly solubilized fragments of phospholipid bilayer are
immunoprecipitated together (Herrera et al., 2006). But
Table 1
Symbols of quantities and parameters a
I The average relative infectivity of a virion.
p The probability that a protomer is functional.
q The probability that a trimer is functional.
C, r, R, P, N Standard symbols in combinatorial and probability analysis; the
number of ways of combining r objects out of N is expressed
as NCr=N!/(r!(N− r)!). P(R) is the probability of R. (This R is
unrelated to the R2 that is a measure of the goodness of fits.)
n The number of trimers per virion. For virions with mixed Env,
n is the number of functional trimers plus the number of trimers
that are inactive because of incorporation of inert Env. Thus n
does not include spontaneously inactived trimers.
S Number of non-functional protomers that inactivate a trimer.
L Number of non-functional trimers that inactivate a virion.
T Minimum number of functional trimers a virion requires for
infectivity.
a Parameter allotting weight to liminal or incremental
component in a model spectrum at the level of the virion.
Constrained as 0≤a≤1; the greater the value of a, the more
weight is given to the incremental component.
c Coefficient allotting weight to a particular threshold, i.e., to a
value of L in a gradual liminal model.
b Parameter given various exponents (z=[0, 1, 2, 3]) that give
optimal values to the coefficients for each respective threshold;
constrained to b≥1.
h Parameter giving weight to protomeric contributions to trimer
function along the spectrum from S=1 to proportionally
incremental effects of protomers, 0≤h≤1; the greater the
value of h, the more weight given to the incremental protomeric
component.
a Since the current modeling is more comprehensive and complex than that in
Herrera et al. (2006), and in order to maximize consistency with the rest of the
literature, some of these symbols differ from those in that reference or signify
quantities that are not found there.
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independence. The latter has been obtained for influenza HA
trimerization: when sufficiently similar HA protomers oligo-
merize, the relative frequency of hetero-trimers conforms to the
predicted binomial distribution (Boulay et al., 1988). In contrast,
HIV-1 and -2 Env co-expression gives rarer hetero-trimer
formation than independence would predict. It can be argued but
not proven that the combinations of the more similar forms of
Env that are analyzed here have a correspondingly weaker
tendency to favor homo-oligomerization. But the point is that
any deviation from random trimerization can lead to spurious
inferences from binomial analyses. This caveat deserves to be re-
entered and mathematically explicated at the two levels of
analysis: the trimer and the virion.
We call the total number of potentially functional trimers per
virion n. If we postulate a threshold, L (Fig. 1C), of the number
of trimers that must be inactivated for the virion to lose
infectivity, the fraction of infectious virions, i.e., the relative
infectivity will be:
IL ¼
Xn
r¼ðnLþ1Þ
nCrq
rð1 qÞnr ð1Þ
(see Table 2 andMethods). Conversely, we let T be the minimum
number of functional trimers required for infection. Initially, wepostulate n=9. This value is the average total number that has
been described for HIV-1 (Zhu et al., 2003). But it could also be
viewed as a realistic number of functional trimers for virions
with a higher total number of trimers, some of which have
decayed spontaneously (cf. Briggs et al., 2004; Chertova et al.,
2002; Poignard et al., 2003; Zhu et al., 2006).
Figs. 1D–F illustrate these different possibilities of
absolute requirements at the trimer and virion levels.
Obviously, the relative infectivity at a certain value of p
will be lower if one non-functional protomer knocks out the
trimer (S=1, as in Fig. 1D), than if trimer inactivation requires
a greater number of protomers to be inert (S=2 or S=3, as in
Figs. 1E and F).
Comparison with data on phenotypically mixed virus
The relevant empirical studies have expressed infectivity
and neutralization of phenotypically mixed viruses in disparate
manners. In order to model all these data comparatively, they
were converted here to a uniform format: relative infectivity on
the y axis and the proportion of functional Env protomers on
the x axis. Fig. 2A shows pooled relative infectivities from two
studies on viruses with mixed cleavage-competent and
-defective Env (Herrera et al., 2006; Yang et al., 2005b). It
also shows the mean relative infectivities of viruses bearing
wild-type Env mixed with mutants defective in binding to CD4
or to coreceptors (Yang et al., 2006a). Furthermore, it shows
the mean relative infectivities of virus with mixed antigenic
and non-antigenic Env in the presence of NAbs (Yang et al.,
2005a). Further details on the pooling and averaging of data
are given in the legend to Fig. 2A. In brief, since information
about intra- and inter-experimental variation, as well as about
biological variation between strains and NAbs, differs among
the data sets, only a mean relative infectivity value (I) per
relative Env content value (p) has been used within each
modeled data set. More definitive differentiation between
models, with the theoretical uncertainty discussed here, would
require fits based on a large number of replicates of each
experimental condition and smaller incremental steps in p. The
data from the earlier neutralization work (Schonning et al.,
1999) are not included in this re-analysis because of the
considerably greater experimental variation in that study. In
each of the three categories of data (neutralization, cleavage
defect and receptor-binding defect), curves are plotted
separately for T-cell line-adapted viruses (TCLAs) and primary
isolates (PIs).
Some of the variation in the re-plotted data in Fig. 2A is
experimental, but some of it may reflect genuine differences
between strains and mutants. The curves for TCLAs consistently
fall below those for PIs. However, the differences between the
three categories – cleavage-defective Env, receptor-binding-
defective Env and neutralization – are also apparent. Even for
the neutralization data, for which the PI-TCLA difference was
the smallest, at p=0.80, the PI I values were significantly higher
than the TCLA I values: representative single-experiment I
values for 7 PI-NAb combinations (3 isolates and 2–3 NAbs) vs.
8 TCLA-Nab combinations (1 isolate and 8 NAbs) (Yang et al.,
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whether the observed difference was significant, P=0.003).
Although the NAbs were not the same in the two groups, this
difference is compatible with a generally greater neutralization
resistance of PIs than of TCLAs.
Cleavage-defective Env has been called dominant-negative
because of its strong interfering effect (Herrera et al., 2006;
Iwatani et al., 2001; Yang et al., 2005b). In contrast, CD4- and
coreceptor-binding-site Env mutants seem to interfere less
strongly with wild-type Env in the phenotypically mixed virus
than does cleavage-defective Env, although the former Env
mutants on their own confer no significant residual infectivity
(Yang et al., 2006a). Furthermore, the curves for the
neutralization data are lower than most of the others; this
indicates that NAbs interfere with Env function moreeffectively than do some defective forms of Env. Finally, the
theoretical curves in Fig. 1 are noticeably steeper than the
empirical ones in Fig. 2A. Why do the models thus disagree
with the data?
The total number of trimers per virion, n, affects the steepness
of the theoretical curves. In Fig. 2B, the relative value of the
threshold at the level of the virion, L, is kept fixed at the median
threshold (and S=1), while n is varied. As n goes from 3 to 81,
the slope gets steeper and the similarity to the data decreases.
Does this mean that the premise of a high n is wrong or are other
aspects of the modeling responsible for the gap between theory
and data? This is uncertain. On the one hand an infectious virion
may have higher n than the average virion; on the other hand, n
is the sum of active trimers and those that are inactive only
because of incorporation of inert protomers; n does not include
Table 2
General definitions and equations of pure liminal and incremental models at the
virion level
Liminal model Incremental model
Definition A virion is infectious if it has at
least a minimum number of
functional trimers.
Each functional trimer
contributes equally and
independently to virion
infectivity.
Basic equation
if S=1
IL ¼
Pn
r¼ðnLþ1Þ
nCrqrð1 qÞnr
Eq. (1) where q=p3
I=p3
Eq. (2)
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may represent only a fraction of the physically detectable trimers
on a virion. Furthermore, it should be emphasized that any
deviation from randomness, i.e., from the independence of the
combinatorial events, towards a tendency for preferential homo-
oligomerization, or for homogenous incorporation of trimers
into virions, would flatten the curves; this could therefore also
lead to spuriously low apparent n.
In general, closeness to the data is a problematic criterion for
choosing between the models. It is impossible for the data to
differentiate among the plethora of theoretical possibilities. The
Supplement illustrates this problem of model redundancy.
If the fit is better the lower the value of n, there may be the
temptation to conclude that virions usually only have one trimer,
which is precisely what they require for infectivity (Yang et al.,
2005a,b, 2006a). Fig. 2C shows the three curves for n=1, L=1,
T=1 and S=[1, 2, 3]. However, the samemathematical functions
correspond to a principally different kind of model as well:
proportionally incremental effects of functional Env on
infectivity, i.e., a complete absence of thresholds at the virion
level. According to the incremental hypothesis, a virion with
nine functional trimers has exactly nine times greater propensity
to infect than one that has a single trimer. Yet another possibilityFig. 1. Absolute–liminal models at both the trimer and the virion level. (A) The cartoo
as groups of three spheres, each sphere being either an active (blue) or an inert (red) S
row of the figure illustrates all the possible combinations of active and inert protome
S=1 means that one inactive protomer is sufficient to knock out the function of a t
functional. When S=2, i.e., the threshold for trimer inactivation is two inert protom
means that the only inactive trimers are those with three inert protomers; all the trim
models do not allow for any intermediate activity of mixed trimers. (B) The cartoon ill
different causes. In one situation, wild-type Env is active but mutant Env is defective
wild-type Env is inactivated by the binding of NAbs (magenta Y shapes in lower row)
contains amino-acid changes that prevent NAb binding while not compromising Env
virions. Blue trimers are active, whereas red trimers are rendered inactive because the
spontaneously inactivated over time by a constitutive process associated with decay
spontaneous inactivation. A threshold for virion inactivation of at least four inactive
virion requires is set at six; i.e., T=6. The virion on the left, with seven functional trim
functional trimers, is non-infectious. (D–F) The total number of trimers per virion is a
et al., 2003). All possible discrete thresholds are illustrated: L, the minimal number of
1 to 9. The diagrams show the relative infectivity on the y-axis as a function of the re
axis). The graphs show the consequences of three different assumptions about trimer
S=1; (E) two non-functional protomers are required to inactivate a trimer, S=2; (F
diagrams (D–F) L=1, green triangles; L=2, blue triangles; L=3, red triangles; L=4,
blue circles; L=9, red circles. It is apparent that the slopes of the curves for the sa
thresholds at the trimer level, S: e.g., the three left-most (L=9) curves in the three di
same three diagrams. Furthermore, when instead S=1 is kept constant, the slope of the
more of a parallel shift (E), and for S=3, the slope instead becomes steeper as L incis that each protomer contributes to the infectivity in a propor-
tionally incremental manner. Such a protomer-incremental func-
tion is represented by the linear, diagonal curve in Fig. 2C. That
model stipulates no thresholds at either virion or trimer level.
But for now we assume S=1, as proposed (Herrera et al.,
2006; Yang et al., 2005a,b). We then explore a spectrum of
models between an incremental and a liminal pole.
Fitting data on a spectrum between liminal and incremental
models
As a rough adjudication between the two kinds of model, the
simple incremental model
I ¼ p3 ð2Þ
was compared consecutivelywith liminalmodels having different
numbers of trimers per virion (n=[5, 9, 15, 45]) and all possible
thresholds, L, described by I ¼ P
n
r¼ðnLþ1Þ
n Crqrð1 qÞnr
(Eq. (1), Table 2). The closeness of the data to either kind of
model was determined along the spectrum by fitting the
parameter a in
I ¼ ap3 þ ð1 aÞ
Xn
r¼ðnLþ1Þ
n Crq
rð1 qÞðnrÞ ð3Þ
where 0≤a≤1 (Table 1). A small value of a thus indicates
closeness to a particular liminal model; a large value suggests
proximity to the incremental alternative. In Fig. 3, the parameter
a, fit to the data (Herrera et al., 2006; Yang et al., 2005a,b; Yang
et al., 2006a), is plotted for each L.Only fits yielding R2N0.9 are
displayed and the standard error of the non-linear regression
indicates the uncertainty of the results. The rationale is not to
find optimal modeling but to locate any zones of L values that
make liminalmodels good competitors with the incremental one.n illustrates an all-or-nothing model of Env function. Env trimers are represented
U-TM hetero-dimeric protomer. The array of four different trimers in the middle
rs. Below, three different thresholds for inactivation of the trimer are stipulated.
rimer completely; only homo-trimers consisting purely of active protomers are
ers, only trimers with zero or one inactive subunit are functional. Finally, S=3
ers with one or more active protomers are equally functional. Note that these
ustrates that the same basic modeling applies to Env that is active or inert through
in a vital function (red spheres with yellow crosses in the top row). Alternatively,
, which are present in excess. In this situation, the mutant Env is active because it
function. (C) Three kinds of trimers are shown on the surface of the two model
y contain inert protomers, as outlined in panels A and B. Grey trimers have been
of infectivity. Both model virions bear nine trimers (n) that have not undergone
trimers is postulated; i.e., L=4. Thus the minimum number of active trimers a
ers, is therefore infectious, whereas the virion on the right, which has only four
ssumed to be constant, n=9, an average that has been described empirically (Zhu
trimers that have to be inactivated for the virion to lose its infectivity, ranges from
lative amount of functional Env protein that was incorporated into the virions (x-
function: (D) one non-functional protomer per trimer is sufficient to inactivate it,
) three non-functional protomers in the trimer render it inert, S=3. In all three
green squares; L=5, blue squares; L=6, red squares; L=7, green circles; L=8,
me threshold at the virion level, L, vary drastically between different protomer
agrams D–F (S=1, 2 or 3), or the corresponding right-most (L=1) curves in the
middle of the curve flattens as one goes from L=1 to L=9 (D); for S=2, there is
reases (F). It is also apparent that the ranges of the curves overlap widely.
250 P.J. Klasse / Virology 369 (2007) 245–262The dips on the curves in Fig. 3 indicate which threshold, L,
brings the liminal model closest to the data. (In some cases mid-
point thresholds between two adjacent values of L in a zone of
minimal a have also been explored.) TCLA and PI viruses differ
in all diagrams in Fig. 3. The TCLAs tend to approach lower
thresholds than the PIs.
Panels A–E in Fig. 3 show data from neutralization
experiments (Yang et al., 2005a). Deviations from the incre-
mental model are small. And they are still smaller for the PI than
for the TCLA. The preferred threshold for each is nevertheless
nearly constant as a fraction of the varied total number of trimers,
n: about 30% for the TCLA and 90% for the PI. (In addition
minute deviations of a from 1 are observed at low L values for
the PI.) This would make the TCLA more neutralization-
sensitive than the PI, all other things being equal. Yet, of course, itFig. 2. Comparison of models and data on phenotypically mixed virus. (A) Data
from four empirical studies were converted to a common format, for ease of
comparison. All curves for PIs are continuous lines with circles; TCLA viruses
are represented by stippled lines and squares. The data from two studies on
phenotypically mixed cleavage-defective and cleavage-competent Env are
represented by the blue curves; only data from experiments using Env with
full-length cytoplasmic tails were included (Herrera et al., 2006; Yang et al.,
2005b). The PI curve (blue continuous lines, circles) shows the pooling of data
from the PIs YU2 (Yang et al., 2005b) and JR-FL (Herrera et al., 2006). (Neither a
fusion-segment mutant (V513E) nor cytoplasmic-tail andmatrix-protein mutants
described in (Yang et al., 2005b) are included in the current re-analysis.) The data
for the TCLAvirus HXBc2 (Herrera et al., 2006) (blue stippled lines, squares) fall
below. Two neutralization curves are shown in green (Yang et al., 2005a). The PI
curve represents the mean of data for three strains and three NAbs (green
continuous line, circles). The TCLA curve describes the mean of data on HXBc2
and 8 NAbs; it falls somewhat below (green stippled line, squares). The red
curves show average data for viruses containing wild-type Env and Env with
defects in receptor interactions (Yang et al., 2006a). The PI curve (red continuous
line, circles) shows the mean of data for YU2 viruses containing Envwith defects
in either CD4 or CCR5 binding. The TCLA curve depicts the mean of data for
HXBc2 viruses containing Env with defects in either CD4 or CXCR4 binding.
Insufficient information is available to illustrate experimental variation or to
separate it from biological variation. Data sets for some mutants and similar
strains – pooled here in order to indicate approximate trends – were analyzed
separately in the following. (B) The number of trimers per virion affects the slope
of the curve. The diagrams show the relative infectivity on the y-axis as a function
of the relative content of functional Env protein that is incorporated into the
virions (x-axis). The steepness is determined by n, the number of functional
trimers per virion at p=1: the absolute threshold, L, is assumed to be constantly
the median, (n+1) /2, for four odd values of n from 3 to 81. In all four cases, one
non-functional protomer per trimer is assumed sufficient for inactivating the
trimer, i.e., S=1; n=3, L=2: red circles; n=9, L=5: blue circles; n=27, L=14:
green circles; n=81, L=41: magenta circles. (C) Proportionally incremental
models. Incremental models based on the assumption that virion infectivity is
exactly proportional to trimer functionality are illustrated. They are independent
of the value of n. The three special cases of protomeric thresholds at the trimer
level, S=1 (red circles), S=2 (blue circles), S=3 (green circles) are illustrated. In
addition, a protomeric incremental model, i.e., the absence of thresholds at both
the trimer and virion levels, is shown (magenta circles). This function is also the
average of those for S=1, S=2 and S=3. Mathematically, models of the extreme
case of n=1 and T=1 will be identical to the incremental ones for S=1, S=2,
S = 3 here, but their interpretations and implications differ.does not exclude affinity as a dominant influence on neutraliza-
tion sensitivity (Klasse and Moore, 1996; Yang et al., 2006b).
Panels F–J of Fig. 3 model the same spectra between
incremental and liminal extremes for data on wild-type Env
mixed with cleavage-defective mutants (Herrera et al., 2006;
Yang et al., 2005b). Again, the TCLA approximates lower
thresholds than the PIs. The TCLA thresholds are 30–50% of n
and the PI thresholds 70–80% of n. These data are close to the
liminal end of the spectrum, particularly for the PI strain JR-FL.
For example, a purely liminal model, S=1, n=5, L=4 and a=0,
gave R2 =0.9753. This is higher than that of the rigid model with
S=1, n=1, T=1 proposed in Yang et al. (2005b) and applied to
the JR-FL data (Herrera et al., 2006): R2 =0.8390.
Panels K–N of Fig. 3 show that the receptor-binding and
fusion-segment mutants (Yang et al., 2006a) differ from the
others. In contrast to the mutants in Figs. 3A–J, the L values at
the a minima coincide for the TCLA and PI mutants, at about
80% of n. The mutants segregate in another way: TCLA CD4-
and CXCR4-binding and the PI fusion-segment mutants
251P.J. Klasse / Virology 369 (2007) 245–262generally fit well (R2 peaksN0.99, not shown) on the spectrum
and often better than to the proposed model (n=1, T=1, S=2
(Yang et al., 2006a)), although S=1 is here kept constant along
the whole spectrum. Furthermore, the a minima for those three
data sets are not as low as for the PI CD4- and CCR5-binding
mutants. The latter two mutants tend more closely towards the
liminal pole but still fit poorly along the spectrum.
In conclusion, Fig. 3 illustrates differences both among
strains and mutants. It gives strong evidence for specific
thresholds that are relatively constant as a proportion of the
assumed total number of trimers, n. But it also shows that mixed
liminal–incremental models can fit better than the simpler ones.
In general, a was lower for the lower values of n, as expected
from how n affects the steepness of the curves and thus the
proximity to the data (Fig. 2B).
Gradual thresholds
Env trimers mediate a chain of events that culminate in the
release of the viral core into the cytoplasm of the target cell.
How many trimers participate in these events, such as
attachment to CD4, coreceptor interactions and hemi-fusion
culminating in the creation and expansion of a fusion pore? The
answer may not be a single integer. Different numbers of
molecules may be involved in the distinct steps. Cellular factors,
such as receptor density, may influence how many trimers are
needed. And infectivity may dwindle at low trimer numbers
without disappearing entirely.
Furthermore, populations of virions are heterogeneous. The
number of functional trimers on the surface of virions varies.
And this number may be declining over time because of
shedding of SU, conformational inactivation or de-oligomeriza-
tion (Moore et al., 1990, 2006; Poignard et al., 2003).
Env trimers form clusters over the virion sphere (Zhu et al.,
2006). Random constellations of active trimers will differ and
may confer distinct infectious propensities to the virion. Only
adjacent trimers might function together (Fig. 4A). The spherical
distribution of trimers could thus add to virion heterogeneity.
These influences may render the apparent n lower than the
real one. Indeed closeness to liminal models generally increased
with diminishing n in Fig. 3. Thus as a compromise among all
considerations of the relevant number of active trimers per
virion, the continued modeling was done with n=9.
All the outlined heterogeneities may result in a softening of
the virion-level thresholds. The soft-threshold models for
virions with 9 trimers are given by th equation
(4)
I ¼ ðc1IL¼1 þ c2IL¼2 þ c3IL¼3 þ c4IL¼4 þ c5IL¼5
þ c6IL¼6 þ c7IL¼7 þ c8IL¼8 þ c9IL¼9Þ
=ðc1 þ c2 þ c3 þ c4 þ c5 þ c6 þ c7 þ c8 þ c9Þ
where IL ¼
P9
r¼ð9Lþ1Þ
9Crqrð1 qÞ9r (Eq. (1) with n=9).
The coefficients, c1− 9, give weights to the thresholds. In
order to reduce the number of parameters for fitting by non-
linear regression, one can let cL=b
z. Then the exponent z can be
given different constant, low, arbitrary, whole-number values toplace more or less weight on the different thresholds. If linear
regression gives bN1, that favors a gradual-liminal model over
a purely incremental one. If all potential thresholds are blended
in (all cL=b
z), and b=1 gives the best fit, that refutes any
tendency towards a threshold. The model then coalesces with
the proportionally incremental ones in Fig. 2C for the respective
S. Conversely, a best fit with bN1 refutes a purely incremental
model, although it does so with a certain risk of over-fitting the
data.
Figs. 4B and C and Supplementary Figs. 3 and 4 illustrate
how different virion heterogeneities and incremental effects,
one kind at a time, may soften thresholds and thereby reduce the
slope of the infectivity curves. In reality, all these blurring
effects may combine.
Differential protomeric contributions
As argued in the Supplement, if S=1 (q=p3) does not give
good fits there are more plausible other options than S=2 or
S=3. One is a proportionally incremental protomeric contribu-
tion to trimer function, q=p. This can be interpreted as a
probability or a propensity: the chance of the all-or-nothing
functioning of a trimer varies with its content of functional
protomers; or the biochemical capacity of the trimer takes four
values, 0, 1/3, 2/3 and 1. Combining S=1 and incremental
protomeric contributions, one can ask where within such a
spectrum the relative trimer function, q, lies:
q ¼ hpþ ð1 hÞp3 ð5Þ
Fig. 4D illustrates trimer function for different values of h
between 0 and 1. Any deviation from S=1 decreases the
steepness of the curve. The parameter h is constrained
(0≤h≤1) and can be fit (simultaneously with b at the virion
level) by non-linear regression.
Thus allowing threshold flexibility at both levels, one can
optimize the mixed model. This is illustrated in Table 3 and
Fig. 5.
The combined liminal–incremental models of neutralization
and cleavage-defective Env are close to the assumption of S=1
at the trimer level (h remains low in Table 3). There are,
however, even in those categories two deviant h values, 0.10
and 0.39, for the cleavage-defective mutants of the PIs. The
models for receptor-fusion-defective Env deviate considerably
more from S=1: h ranges from 0.21 to 0.94. This variation
among those five fits may be accidental. For it illustrates the
interconnectedness of the thresholds at the two levels: the lower
the value of L, the higher the value of h. As shown in
Supplementary Table 2, models with either L=5 or L=8 can fit
all five data sets approximately equally well. When L=5, h
ranges from 0.7 to 1.0. When L=8, h ranges from 0.21 to 0.31.
When L=5, the model approaches incremental protomer
contribution. Whether L=8 or L=5, however, the first protomer
that is knocked out reduces trimer function by at least a third,
often more. In contrast, a previous model (Yang et al., 2006a)
postulated that the first and third receptor-binding or fusion-
segment mutant protomer had zero effect. It is also pertinent that
a distinct fusion-segment mutant (V513E in YU2 Env (Yang et
252 P.J. Klasse / Virology 369 (2007) 245–262al., 2005b), not analyzed here) was previously identified and
found to require S=1. Thus, although mutants seem to differ,
there is no salient dichotomy among them.
The current variation in h proves two points: first, the more
universal the peak in weight given to L values, e.g., around 5–6
(corresponding to a T of 4–5), the clearer the difference in h
becomes between the neutralization and cleavage-defective Env
models, on the one hand, and the receptor-fusion-defective
models on the other. Secondly, within the mixed liminal–
incremental models, deviations from S=1 can be satisfactorily
accommodated by incremental protomer contributions without
any need for postulating S=2.Still, as mentioned in the Introduction, any deviation from
randomness, i.e., from the independence of the combinatorial
events analyzed, could have devastating effects on the validity
of inferences to the best model. Specifically, if only homo-
oligomerization occurred, that would simulate total protomeric
incremental effects at the trimer level; for trimer activity would
be strictly proportional to p. The apparent h would be=1 but
that would not be because of incremental protomeric contribu-
tions to trimer function. More plausibly than such an extreme
situation, mutants may deviate slightly and differentially from
randomness in their oligomerization with wild type. This source
of erroneous stoichiometric interpretations must not be
Fig. 3. Closeness of data to models along liminal–incremental spectra. All panels represent spectra between one incremental and a variety of virion-level liminal
models. Both the incremental and the liminal models have S=1 as a premise. Virions are postulated to have 5, 9, 15 or 45 potentially active trimers in total (n, marked
above each diagram). The threshold of inactivation, L, in the liminal component of the model spectrum is depicted on the x-axis. On the y-axis, the value of the
parameter a±SEM, optimized by non-linear regression, is expressed for each value of L. The parameter a, constrained 0≤a≤1, gives the differential weights to the
incremental and liminal components of the model spectra: the higher the value of a, the greater the incremental component; the lower the value of a, the greater the
liminal component. Thus a minimum on the curve indicates the greatest proximity to the liminal function with that particular threshold. The R2 value corresponding to
the minimum a value is invariably among the higher ones. But other adjacent thresholds, with a higher a, can sometimes give even higher R2 values. For some data
(Yang et al., 2006a), the incremental and some liminal models fit so poorly that no good fit was found within the spectrum between them. Such a values giving R2b0.9
have not been plotted. Panels A–E show modeling of virus with mixed antigenic and non-antigenic Env in the presence of an excess of NAb (Yang et al., 2005a), the
TCLAvirus HXBc2 (mean of I for 8 NAbs, red circles) and the PIs YU2, ADA and KB9 (mean of pooled I for 2–3 NAbs, blue squares). Panels F–J show modeling of
virus with mixed cleavage-defective and functional Env: the TCLAvirus HXBc2 (Herrera et al., 2006) (red circles); the PI YU2 (Yang et al., 2005b) (blue squares) and
the PI JR-FL (Herrera et al., 2006), green triangles. Panels K–N show viruses containing mixed mutant and wild-type Env, where the mutant is defective in CD4
binding, coreceptor interaction or gp41-fusion function (Yang et al., 2006a). The TCLA virus HXBc2 has varying proportions of Env defective in binding CD4 (red
circles) or CXCR4 (black diamonds); the PIs have varying proportions of Env defective in binding CD4 (blue squares) or CCR5 (magenta diamonds) or in respect of
the fusion function of gp41 (orange triangles). A, F and K: n=5. B, G and L: n=9. C, H and M: n=15. D and I: n=45, the threshold L varied from 1 to 16. E, J and N:
n = 45, the threshold varied from 29 to 45.
253P.J. Klasse / Virology 369 (2007) 245–262dismissed. Ideally, it ought to be addressed through immuno-
precipitations for different values of p (cf. Boulay et al., 1988).
Correspondingly, any tendency for homogenous incorporation
of trimers into virions would militate against manifestation of
the threshold effects predicted from binomial assumptions: the
apparent b would be spuriously low.If, however, there is a difference in threshold at the trimer
level between cleavage-defective and other mutations, the
cleavage-defective more dominant-negative effect may not best
represent the true contribution by subunits to trimer function:
the uncleaved polypeptide chain, with its different conforma-
tion, may pose a steric impediment to the function of the other
Fig. 3 (continued).
254 P.J. Klasse / Virology 369 (2007) 245–262two. The fusion-segment mutants should best address the
number of subunits participating in the fusion reaction. But a
strong negative effect of the first inert protomer cannot be
refuted even for that reaction (Table 3, Supplementary Table 2).
In the three panels in Fig. 5, the TCLA curves fall below the
corresponding PI curves. As shown in Table 3, this is reflected
in somewhat lower threshold values for TCLA than for PI virus
(cf. Klasse and Moore, 1996), at the virion level in the case of
neutralization and the cleavage defect, as well as at the trimer
level for the receptor-binding site and fusion-segment mutant.
Whether this is a real biological difference or not, in order to
represent it, a model requires plasticity and therefore complex-
ity. Although only two parameters are fit in the final modeling,
already that goes beyond the power of the existent data to
discriminate unambiguously between different options. A
strong caveat must be entered because of the great number of
assumptions about the variables that are not fit. The complexity
also carries a risk of overfitting the data.
That risk is particularly great for the model chosen to fit the
PI neutralization data. As shown in Table 3 and by the equation,
that model differs from all the others by encompassing two
peaks in weights given to thresholds: a high and a low one. The
very minor deviations from a purely incremental model in Fig. 3
also suggested this distribution of the data. A speculative
interpretation of such a double-threshold model would be thatthe first Ab gives a slightly greater dent in the infectivity than
the subsequent ones. But then when two-thirds of the trimers are
occupied the infectivity declines more sharply; each Ab that
binds reduces the infectivity but not to entirely equal extents
along the whole gamut. Such a view is possible. But much more
detailed and precise data would be required to rule out a simpler
model, e.g., a low and broad peak in L around 5, which fits so
many of the other data sets excellently (Table 3 and
Supplementary Table 2).
The excellent fits notwithstanding, all current modeling thus
remains tentative. This is so not only because of uncertainty about
premises, data imprecision, too few data points for discriminating
between models and possible systematic errors in wild-type and
mutant mixing and incorporation, but also because of model
redundancy that arises partly from compensatory effects at the
two levels of modeling (Supplementary information).
Overall, the modeling suggests real thresholds of inactiva-
tion that are blurred by virion heterogeneities and that may co-
exist with real incremental effects.
Discussion
When an HIV virion has landed on the cell surface, a certain
number of Env trimers will initially dock on to receptor
molecules. Subsequently, infection may not ensue unless
255P.J. Klasse / Virology 369 (2007) 245–262additional Env trimers make contact with receptor and coreceptor
molecules. Such recruitment would ultimately create a fusion
complex of Env, CD4 and coreceptors. We do not know the
minimal numbers of the different components that comprise such
a complex. Yang et al. (2005a,b, 2006a) posit that one trimer per
virion is a sufficient and indeed the typical Env contribution to
the fusion reaction. The modeling performed here gives
alternative accounts of the data. Both kinds of modeling can
approximate the data on virus pseudotyped with wild-type and
mutant Env, although the current more flexible functions can
yield superior fits (Table 3). In order to decide between these
alternatives, however, one also needs, first, to scrutinize the
realism of their premises. Then one has to examine whether they
agree with various other independent bodies of data, distinct from
those on mixed pseudotypes of wild-type and mutant Env.
Yang et al. (2005a,b) argue that since most virions are not
infectious, the infectious minority on average has close to the
minimum number of trimers, T, which they call an “infectious
unit”. But such a paucity of infectious capacity would not
exclude all spare capacity of Env: if n=9 and T=5, the spare
capacity would be 4 trimers. Thus even if virions rarely had
double the minimal number of trimers (nb2T or less than twoFig. 4. Virion heterogeneities can soften thresholds. (A) The cartoon shows how
heterogeneity in Env distribution over virion spheres can soften threshold effects.
The virions all have 16 trimers (active in blue, inert in red). In the top row, the
virions have eight active trimers, in the bottom row, only four. If the condition for
infectivity is a minimum of four contiguous trimers, infectivity will be common
among the virions in the top row, but rare among those in the bottom row. Thus
the number of active trimers will affect the probability that the requisite number
will be present in a contiguous constellation conducive to infectivity; this scheme
differs from the all-or-nothing effect of thresholds on infectivity that is
determined solely by the number of active trimers regardless of how they are
spread over the virion sphere. The consideration of spherical distribution causes a
softening of the infectivity thresholds. Different spatial constellations of a the
same number of contiguous trimers may also have different propensities to
function in entry, a further blurring effect. In addition, any spare trimers that are
outside entry-competent constellations could still modulate infectivity by
contributing to virus–cell attachment, creating yet more blurring of any simple
threshold effect. (B) If the infectivity of the average virion is neither all-or-
nothing nor exactly proportional to the number of functional trimers present, then
a certain proportion of inert trimers would reduce the relative infectivity dis-
proportionately without eliminating it. The infectivity may drop more
precipitously in an intermediate zone than when the first and last trimers are
knocked out. Suchmixed liminal–incremental models assign different weights to
each absolute–liminal equation. We assume n=9. Three curves for a soft thres-
hold around L=5, I=(IL=1+bIL=2+b
2IL=3+b
4IL=4+b
8IL=5+ b
4IL=6+b
2IL=7+
bIL=8+ IL=9) / (2+2b+2b
2+2b4+b8) are shown with a low (b=2) (blue squares),
intermediate (b=1.3) (green triangles), and high (b=1.1) (red circles) degree of
softness of the threshold. (C) Three curves with the same three values of b as in
panel B for a low threshold around L=2, I=(b6IL=1+b
9IL=2+b
6IL=3+b
5IL=4+
b4IL=5+b
3IL=6+b
2IL=7+bIL=8+ IL=9) / (1+b+b
2+b3+b4+b5+2b6+b9) (b=2,
red circles; b=1.3, blue squares; b=1.1, green triangles) and three for a high
threshold around L=8, I= (IL=1 + bIL=2+ b
2IL=3 + b
3IL=4 + b
4IL=5 + b
5IL=6 +
b6IL=7+b
9IL=8+b
6IL=9) / (1+b+b
2+b3+b4+b5+2b6+b9) (b=2, orange circles;
b=1.3, black squares; b=1.1, magenta triangles). (D) The blending of the two
most realistic models at the trimer level, S=1 and the protomer-incremental one,
is shown. Five different curves on the spectrum between the two extremes are
shown for values of the parameter h=0 (magenta circles), h=0.33 (red circles),
h=0.5 (blue circles) h=0.67 (green circles) and h=1 (black circles). Note that
unlike in the other diagrams, the y axis here represents the relative trimer
function, q.
Table 3
Comparison of a flexible model based on n=1, L=1, T=1, and S=1 or 2, with the best mixed liminal–incremental models
Neutralization a Cleavage-defective a Receptor-fusion defective a
TCLA PI TCLA PI YU2 PI JR-FL TCLA CD4− TCLA CXCR4− PI CD4− PI CCR5− PI fusion−
Previous models T=1,
S=1 or S=2 b
R2 0.99 0.9980 0.99 0.98 0.90 0.97 0.96 0.98 0.9981 0.97
k 0.96±0.026 1.0±0.013 0.99±0.038 1.1±0.049 1.2±0.11 0.88±0.048 0.87±0.053 1.1±0.036 0.98±0.012 0.89±0.045
Mixed incremental–
liminal models
R2 1.0c,d 1.0c,e 1.0c,f 1.0c,g 0.99c,h 1.0c,i 1.0c,i 1.0c,j 0.9999c,k 1.0c,i
Peak in threshold weight
at virion level
L 2 1, 7, 8 4, 5 7 6 8 (5) l 8 (5) l 7 (5) l 5 8 (5) l
Weight of virion-level
threshold
b 1.2±0.0038 1.3±0.025 2.0±0.18 1.2±0.051 3.2±1.4 2.3±0.11 2.0±0.023 7.3±0.87 2.0±0.056 2.0±0.29
Protomeric spectrum
weight
h 0.083±0.0039 0.0086±0.0050 0±0.026 0.10±0.024 0.39±0.068 0.21±0.019 0.24±0.0054 0.60±0.013 0.94±0.0067 0.31±0.069
Akaike's corrected
score difference, |Δ|
Mixed
incremental–
liminal
models
preferred in
all cases
19 1.1 16 9.9 7.9 15 33 12 5.6 1.9
Probability that preferred
model is correct m
N99% 64% N99% 99% 98% N99% N99% N99% 94% 72%
a The neutralization data are from Yang et al. (2005a): the mean I for the TCLAHXBc2 neutralized by 8 NAbs was calculated; the data for the PIs YU2, ADA and KB9 were pooled (mean I for 2–3 NAbs). The data on
cleavage-defective TCLA HXBc2 were derived from Herrera et al. (2006) and on cleavage-defective PI YU2 from (“HIV-1” in Figs. 4B, 5B and 6B in Yang et al. (2005b); neither a fusion-segment mutant (V513E) nor
cytoplasmic-tail and matrix-protein mutants described in Yang et al. (2005b) are included in the current re-analysis; data for cleavage-defective PI JRFL are from Herrera et al. (2006). The mean I values for receptor-
binding- and fusion-defective mutants are given in Yang et al. (2006a,b): the TCLA CD4− is HXBc2 with the Env mutation D368R; TCLA CXCR4− is the HXBc2 Env V3 mutant R308L; PI CD4− is YU2 Env D368R;
PI CCR5− is the YU2 double V3 mutant R315G/L317S; PI fusion− is the YU2 TMmutant L520E. Results have been rounded off to two significant digits except where it would obscure a small difference in R2 between
the models. The R2 values are based directly on the [p, I] coordinates derived from the individual studies. The data points modeled are illustrated by symbols in Fig. 5.
b Previous models for S=1 (Yang et al., 2005a,b) and S=2 (Yang et al., 2006a,b) are here given some flexibility in order to enhance their fits and render them more comparable with the highly plastic liminal–
incremental models. The parameter values T=1, n=1 are shared. For S=1, the equation is I=kp3 (Eq. (9)) and for S=2, it is I=k(3p2−2p3) (Eq. (10)).
c The trimer function is described by the spectrum q=hp+ (1−h)p3 in all equations. The infectivity equation has the same general form as Eq. (4), where IL ¼
P9
r¼ð9Lþ1Þ
9Crqrð1 qÞ9r (Eq. (1) with n=9). The
coefficients cL give different weights to the nine possible thresholds.
d c1=b
2, c2=b
3, c3=b
2, c4=b
1, c5=b
0, c6=b
0, c7=b
0, c8=b
0, c9=b
0.
e c1=b
3, c2=b
0, c3=b
0, c4=b
0, c5=b
0, c6=b
1, c7=b
2, c8=b
2, c9=b
1.
f c1=b
0, c2=b
0, c3=b
1, c4=b
2, c5=b
2, c6=b
1, c7=b
0, c8=b
0, c9=b
0.
g c1=b
0, c2=b
0, c3=b
0, c4=b
0, c5=b
1, c6=b
2, c7=b
3, c8=b
2, c9=b
1.
h c1=b
0, c2=b
0, c3=b
0, c4=b
1, c5=b
2, c6=b
3, c7=b
2, c8=b
1, c9=b
0.
i c1=b
0, c2=b
0, c3=b
0, c4=b
0, c5=b
0, c6=b
0, c7=b
1, c8=b
2, c9=b
1.
j c1=b
0, c2=b
0, c3=b
0, c4=b
0, c5=b
0, c6=b
1, c7=b
2, c8=b
1, c9=b
0.
k c1=b
0, c2=b
0, c3=b
1, c4=b
2, c5=b
3, c6=b
2, c7=b
1, c8=b
0, c9=b
0.
l Alternative models with L peaking at 5 and compensatory, higher values of h are given in Supplementary Table 2. The information content of the current data is insufficient to distinguish between those options but it
should be noted that nearly all data sets fit models with a middle range peak of L excellently.
m The probability the model is correct is calculated from the corrected score difference,Δ, as (e−0.5Δ / (1+e−0.5Δ))*100%. The Akaike term “probability the model is correct” should not be taken literally; it applies only
under the assumption that the two models compared exhaust all possibilities, which, as the bulk of this study shows, is absurd.
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257P.J. Klasse / Virology 369 (2007) 245–262“infectious units” as defined by Yang et al.) that does not
preclude an influence of n on infectivity and its inhibition.
Furthermore, the argument from the rarity of infectious virions
also requires re-examination.
The estimated ratios of infectious units to total number HIV
virions in the range 10−2 to 10−5 (Bourinbaiar, 1994; Klasse
and McKeating, 1993; Layne et al., 1992; Piatak et al., 1993)
must be cautiously interpreted. The fraction of infectious HIV-1
in a suspension of virions that is lost through infection or other
interactions with receptor-bearing cells is negligible (Kabat et
al., 1994; Thomas et al., 2007). This would be in line with the
Law of Mass Action, if the virion concentration is lower than
the virion Kd for the binding to cellular receptors (cf. Yu et al.,1995). Indeed, when viral encounters with target cells are
facilitated, the fraction of virus that infects increases several-
fold (Haim et al., 2007; O'Doherty et al., 2000; Platt et al.,
2005; Thomas et al., 2007). Furthermore, infectivity is lost
through unproductive cell-surface interactions (Platt et al.,
2005). Some of these lead to endocytic internalization and viral
degradation (Marechal et al., 1998). Furthermore, proteasomes
degrade a proportion of viral core particles in the cytoplasm
after fusion (Schwartz et al., 1998). Therefore a large proportion
of the potentially infectious virus that interacts with the
susceptible cells does not give rise to infectious events. This
rationalizes the distinction between infectious and infecting
virus (Klasse, 1996). We cannot measure how much greater is
the potential infectivity of a viral stock than the fraction that
gives rise to diffusion-limited detectable infectious events. But
the ratio of potentially infectious to total number of virions may
not be so low (Thomas et al., 2007), particularly before the
infectivity of a viral stock has decayed substantially. This may
invalidate the inference that each infectious virion has only the
minimal amount of Env required for infection: the amount of
functional Env is not the only limitation of infection. Thus,
having tentatively refuted a central premise for the single-trimer
modeling, we can turn to a number of independent areas where
that model and the mixed liminal–incremental alternative have
divergent implications. The redundancy among all the possible
models (Supplementary information) emphasizes this need to
find independent ways of adjudicating between hypotheses.
An analysis of HIV-1 and -2 neutralization by sCD4 found it
to be proportional to binding up to around 50% occupancy;
higher degrees of binding yielded positive co-operativity (LayneFig. 5. Empirical fit of combined liminal–incremental modeling at both trimer
and virion levels. The optimized liminal–incremental models presented in Table
3 are illustrated graphically. Here n=9 throughout. (A) The infectivity, I, of
virus with mixed antigenic and non-antigenic Env in the presence of an excess of
NAb (Yang et al., 2005a) is expressed on the y-axis as a function of the
proportion of functional Env on the x-axis. The red curve for the function with a
soft threshold around L=2 is shown to fit the data for the TCLA virus HXBc2
(mean of I for 8 NAbs, red circles). The blue curve for the function with
threshold peaks at L=[1, 7, 8] is shown to fit the data for the PIs YU2, ADA and
KB9 (mean of pooled I for 2–3 NAbs, blue squares). (B) The infectivity, I, of
virus with mixed cleavage-defective and functional Env is plotted on the y-axis
with the proportion of cleavable Env on the x-axis. The red curve shows how
well a function with a gradual threshold around L=[4, 5] fits the data for the
TCLAvirus HXBc2 (Herrera et al., 2006) (red circles); the blue curve represents
the function with a gradual threshold around L=7 to fit the data for the PI YU2
(Yang et al., 2005b) (blue squares); the green curve shows how the function with
a threshold of around L=6 fits the data for the PI JR-FL (Herrera et al., 2006)
(green triangles). (C) The infectivity, I, is plotted on the y-axis as a function of
the proportion of active Env on the x-axis for virus with mixed mutant and wild-
type Env, where the mutant is defective in CD4 binding, coreceptor interaction
or in the fusion function of gp41 (Yang et al., 2006a). The liminal–incremental
model curves are shown to fit the data points of the same color: the TCLA virus
HXBc2 defective in binding CD4, L around 8 (red, circles) or CXCR4, L around
8 (black, diamonds); PIs defective in binding CD4, L around 7 (blue, squares) or
CCR5, L around 5 (magenta, diamonds); PIs defective for gp41 fusion function,
L around 8 (orange, triangles). As shown in Supplementary Table 2, L around 5
can fit all these five data sets well with concomitantly high h values. L around 8
can also fit all five well and then the h values are lower. This compensatory
effect of the two soft threshold levels is also seen among the individual five
models in Table 3.
258 P.J. Klasse / Virology 369 (2007) 245–262et al., 1990). This suggests incremental effects on the probability
of docking on to cellular CD4, followed by liminal effects on
virion fusion. It corroborates the involvement of multiple trimers
in entry.
Mathematical modeling of the infectability of cells with
different CCR5 densities suggested that 4–6 coreceptor
molecules are recruited into fusion complexes (Kuhmann et
al., 2000). If Env mediates that recruitment, such interactions
would require more than one Env trimer per virion. Indeed, the
creation of a fusion pore may involve several Env trimers, while
its subsequent dilation requires even greater numbers (Munoz-
Barroso et al., 1998).
A recent electron tomography study of the contact region
between SIV and HIV-1 particles and the surface of susceptible
cells describes an “entry claw” consisting of around five rods
(presumably corresponding to Env trimers making contact with
receptors). Pertinent to the spherical distribution of functional
trimers over the virion surface – as discussed here (Fig. 4A) – is
the observation that the rods in the claw are somewhat closer to
each other than the trimer spikes on free virions (Sougrat et al.,
2007). Of course, there is no telling yet whether the claw is
necessary for entry. Even if it were, that would not preclude that a
single trimer in the claw, surrounded by fusion-defective ones,
effected fusion (Sougrat et al., 2007; Yang et al., 2005b). In
contrast, the binding of NAbs would quite plausibly prevent
claw formation if it left fewer than a handful of contiguous
trimers unoccupied (cf. Yang et al., 2005a); similarly, CD4-
binding capacity of a single trimer would not allow claw
formation, if the rods consist of Env-CD4 complexes (cf. Yang et
al., 2006a). In conclusion, the results from disparate approaches
converge on suggesting that around five trimers per virion, with
a wide range of uncertainty, participate in entry.
HIV-1 fusion is a slow stochastic process; its rate depends on
the density of the molecules involved. Some hybrids between
CD4 and coreceptors yield enhanced infection, possibly because
they obviate the need for a slow coreceptor-recruitment step
(Klasse et al., 1999). And when receptors are sparse, their
clustering in rafts promotes fusion (Gallo et al., 2003). These
characteristics of fusion are more suggestive of multi-molecular
processes than of the mediation of fusion by a single Env trimer.
It has also recently been argued that the rate of infection depends
on what proportion of virions make the requisite number of
CCR5 contacts in order to overcome the activation energy for the
fusogenic conformational changes in gp41 (Platt et al., 2005).
This hypothesis translates into mixed liminal–incremental
effects.
How is infectivity affected by variations in the total number of
trimers per virion? This is highly pertinent to evaluating single-
trimer vs. mixed liminal–incremental models. A truncation of
113 residues from the cytoplasmic domain of SIV Env resulted in
25- to 50-fold increases in the Env content of the virions, which
translated into merely a 2- to 3-fold increase in infectivity (Yuste
et al., 2004). The same truncation in two variants of SIV, with
moderate to high sensitivity to neutralization, increased the
amount of Env incorporated into virions as well as their
neutralization resistance. For a moderately sensitive strain, a
10-fold rise in Env content led to a 24-fold increase in infectivityand a slight increase in neutralization resistance. For the more
neutralization-sensitive variant, a 14-fold rise in Env content
yielded 480-fold higher infectivity and near complete insensi-
tivity to neutralization byAb but not by sCD4 (Yuste et al., 2005).
These non-linear relationships between amount of Env, on the
one hand, and infectivity and sensitivity to neutralization, on the
other, are amenable to quantitative modeling within the mixed
liminal–incremental framework. So is the more extreme finding
of a lack of any additional infectivity per virion with increased
Env incorporation (Lopez-Verges et al., 2006). The latter result
suggests a strong liminal component in an explanatory model.
Neither the single-trimer hypothesis nor the pure incremental
models can account for these non-linear effects.
Regarding neutralization, the hypothesis T=1 (Yang et al.,
2005a) means that only when all trimers are occupied by Ab is
the virion neutralized. Let us assume that the total number of
trimers is around 10. Then the hypothesis T=1 implies that the
neutralizing concentrations will be several-fold above the Kd for
Ab binding to the Env trimer. The Kd for Ab binding to trimeric
Env is thought to be higher than for binding to soluble SU (Kim
et al., 2001; Sattentau and Moore, 1995), although a new study
suggests that is not the case for the binding of the MAb b12 to
trimers of uncleaved Env (Sharma et al., 2006). And some mid-
neutralizing concentrations (IC50) recorded are in a range similar
to those of Kd for SU (Parren et al., 1998). If the IC50 ≤ the
relevant Kd, that refutes the T=1 hypothesis for high values of n.
But this consequence does not arise if T=1 is combined with
n=1, the hypothesis that has been advocated (Yang et al.,
2005a,b). Then the IC50 and the Kd for Ab binding to trimers
would approximate each other (Klasse and Sattentau, 2002);
they would coincide if S=1 and only one Ab can bind per trimer.
Instead, the combination of T=1 with n=1 undermines the
evolutionary explanation for why T would be so low: when
every single Ab that binds to a previously unoccupied trimer
neutralizes a virion, the virus has gained nothing in fitness by
evolving towards such a low T. The requirement of complete
occupancy does not yield a relative neutralization resistance
unless there are several functional trimers per virion to occupy
(Klasse and Sattentau, 2002). In contrast, a high threshold of
neutralization, i.e., a great difference between minimal and total
trimer number would yield that gain in fitness in the presence of
a NAb (Klasse and Moore, 1996).
The multi-trimer hypotheses also more readily explain why
more Ab is required to neutralize virions when the receptor and
cell densities rise (Choudhry et al., 2006; Layne et al., 1991).
Furthermore, if inactivation of Env, by shedding of gp120 or
otherwise, contributes to viral decay in suspension, the liminal
models with nN1 imply increased neutralization sensitivity when
viral stocks age, as observed (Layne et al., 1991). The T=n=1
hypothesis implies no such difference. Indeed, the neutralization-
modulating effects of receptor density specifically strengthens the
case for gradual, i.e., mixed liminal–incremental, models.
Therefore, virion infectivity and its sensitivity to inhibition may
be propensities best described by continuous variables; all-or-
nothing infectivity seems unrealistic (cf. Fig. 4A).
To determine more precisely where in the liminal–incre-
mental spectra the infectivities really fall will require further
259P.J. Klasse / Virology 369 (2007) 245–262investigation of different strains, mutants and Abs (Maloveste
et al., in preparation). It was recently reported that three strains of
HIV-1 with widely different sensitivities to NAbs directed to
natural epitopes acquired similar sensitivity to Abs directed to an
engineered epitope inserted into their respective gp120s (Yang et
al., 2006b). All differences in neutralization sensitivity were
attributed to variations in affinity of the NAbs. This result is
compatible with a strong incremental component in the
neutralization (mathematically similar to T=n=1 but different
in its implications), as suggested particularly for the PI in Fig. 3.
Alternatively, it could result from similar ratios of L to n in
liminal models for the three strains studied.
Post-attachment neutralization of HIV-1 is well-documented,
even for sCD4 and CD4bs NAbs (Lu et al., 1992; McInerney et
al., 1997). It is most readily explained if entry, after initial
attachment to the first CD4 molecule, involves the subsequent
recruitment of additional receptors by neighboring trimers
(Klasse and Sattentau, 2002; Parren and Burton, 2001). That
sequence of events rationalizes the liminal–incremental models.
A parallel may be found in influenza virus infection. Many HA
trimers on a virion initially do not contact sialic-acid receptors.
These so-called “outsiders” nevertheless crucially contribute to
the infectivity of the virion (Leikina et al., 2004).
The enhancement of infectivity by sub-neutralizing concen-
trations of Abs (Schutten et al., 1995; Sullivan et al., 1995) has
been explained by liminal theories of neutralization-critical
levels of occupancy (Burton et al., 2001; Klasse and Burton,
2007; Klasse and Moore, 1996; Morens et al., 1987; Pierson et
al., 2007). Such explanations are not compatible with
n=T=S=1. For under that condition, no intermediate – and
hence no sub-neutralizing – occupancies are possible.
In conclusion, a universal T=n=1 model would not be able
to account for any differences between strains, Abs or kinds of
mutations in relative infectivity as a function of the proportion of
active Env. In contrast, the liminal–incremental models fit data
for different strains, Abs and mutants. Thus, compared with
previous models, the current modeling yields improved fits
based on more rational accounts of protomer contributions to
trimer function and of trimer contributions to virion infectivity.
Overall, the enhanced plasticity may increase rather than com-
promise the realism of the models.
Methods
Derivation of the equations
In relation to cells transfected with two forms of the env gene,
the binomial theorem pertains to two processes: when Env tri-
merizes and when virions assemble. First, it thus applies at
trimerization in the endoplasmic reticulum (ER), where poten-
tially functional Env protomers have a relative frequency of p
and non-functional protomers a relative frequency 1−p. (Strictly
speaking, functionality is merely potential at this stage since the
protomers are not yet cleaved.) The sample space is [0, 1, 2, 3] of
either kind of Env in the trimer. Trimer formation can be regarded
as three trials, N=3, and in each trial the probability that the
protomer incorporated will be functional is the same, p. Thenumber of functional subunits incorporated into a trimer is r.
Thus the probability of r functional protomers in a trimer is
PðR ¼ rÞ ¼NCrprð1 pÞNr
¼ ½N !=ðr!ðN  rÞ!Þprð1 pÞNr
And thus the probability of no functional protomer in a trimer
is P(R= 0) = [3!/(0!(3− 0)!)]p0(1− p)3-0 = (1− p)3 = 1− 3p+
3p2−p3. The probability of only one functional subunit in a
trimer is P(R=1)=[3!/(1!(3−1)!)]p1(1−p)3− 1=3p(1−2p+p2)=
3p−6p2 +3p3. The probability of exactly two functional sub-
units in a trimer is P(R=2)=[3!/(2!(3−2)!)]p2(1−p)3− 2 =
3p2−3p3. The probability of exactly three functional subunits
in a trimer is P(R=3)=[3!/(3!(3−3)!)]p3(1−p)3−3=p3. This ex-
hausts all combinatorial possibilities, because P(R=0)+P(R=1)+
P(R=2)+P(R=3)=1.
We now assume that a trimer is either completely active or
inactive in entry. We call the minimal number of non-functional
Env protomers needed to inactivate a trimer S (see Table 1 for a
list of symbols of quantities). If S=1, then the proportion of
functional trimers is equal to that without any non-functional
trimers in it, i.e., homotrimers of functional protomers, P(R=3)=
p3 which is also 1− [P(R=0)+P(R=1)+P(R=2)].
The non-functional fraction of trimers is [P(R=0)+P(R=1)+
P(R=2)]=1−P(R=3)=1−p3. Thus, naming the functional
fraction of trimers q, for all possible values of S, one gets: S=1,
fraction of functional trimers, q=p3; for S=2, q=3p2−2p3; and
for S=3, q=3p−3p2+p3.
The second cell-biological instance of a possible binomial
distribution occurs at the cytoplasmic membrane, where the Gag
protein drives viral budding. But we do not know how many
Env trimers a virion incorporates. Early electron micrographs
suggested an array of 72 Env spikes per virion (Grewe et al.,
1990). Recently, electron-microscopic analyses concluded that
there are only 8–10 trimers per virion of the HIV-1 strain MN
but 70–79 per virion of some mutants of simian immunode-
ficiency virus (SIV) (Zhu et al., 2003). The number of Gag
protein molecules inside the virion was estimated to be 1400 in
the same study. The number of Env molecules per virion has
also been derived from a ratio of 60 Gag molecules per Env
protomer (Chertova et al., 2002; Yuste et al., 2004). Using that
ratio and a postulated average of 1200–2500 Gag molecules per
virion, the authors estimated that there are 7–14 trimers per
virion. Subsequently, an approximate number of 5000 Gag
molecules per HIV particle was determined by electron
microscopy (Briggs et al., 2004), which would thus yield an
at least two-fold higher range of Env trimers. Adding to the
variability among viruses, varying proportions of SU may
dissociate from TM (Moore et al., 1992). Furthermore, only a
subset of the Env on the virion may be functional (Moore et al.,
2006; Poignard et al., 2003). Therefore, one must explore a
wide range of different total numbers of trimers per virion, when
modeling infectivity.
For simplicity we assume, first, that the virion has 9 poten-
tially active trimers. Secondly, we assume that the incorporation
of functional or non-functional trimers is a random event: every
uptake of a trimer is an independent trial with two possible
ð6Þ
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different fractions of trimers in accordance with the binomial
theorem,
PðR ¼ rÞ ¼nCrqrð1 qÞnr
¼ ½n!=ðr!ðn rÞ!Þqrð1 qÞnr
where r is the number of functional trimers and n is the number
of trimers per virion. Now n=9 and therefore R is a discrete
random variable with sample space [0, 1, 2, …, 9]. For the time
being we make the drastic assumption that a virion only has two
states: infectious or inert. We furthermore assume an absolute
threshold, a minimum integer number of active trimers
necessary and sufficient for infection to occur. It follows that
there is a minimum number of trimers that need to be inactivated
for the virion to be neutralized, which we call L. The minimum
number of active trimers is n−L+1, which is the equivalent of
the minimum number of trimers required for infectivity, called T
in Yang et al. (2005a,b). If L=1, T=9: all trimers are needed for
infection. L=9 would mean that one active trimer is sufficient
for infection (cf. Yang et al., 2005a,b). Generally, for the relative
infectivity, see Eq. (1).
Specifically for Eq. (1) with n=9, we have:
PðR ¼ 0Þ ¼ ð1 qÞ9
PðR ¼ 1Þ ¼ 9qð1 qÞ8
PðR ¼ 2Þ ¼ 36q2ð1 qÞ7
PðR ¼ 3Þ ¼ 84q3ð1 qÞ6
PðR ¼ 4Þ ¼ 126q4ð1 qÞ5
PðR ¼ 5Þ ¼ 126q5ð1 qÞ4
PðR ¼ 6Þ ¼ 84q6ð1 qÞ3
PðR ¼ 7Þ ¼ 36q7ð1 qÞ2
PðR ¼ 8Þ ¼ 9q8ð1 qÞ
PðR ¼ 9Þ ¼ q9
and I ¼
X9
r¼ð9Lþ1Þ
9Crq
rð1 qÞ9r:
A spectrum between incremental and liminal models
In an incremental model, infectivity of a virion is directly
proportional to its number of functional trimers, I=q. In order
to adjudicate between the liminal and incremental possibilities,
we explored the continuous spectrum between them. The
protomer threshold at the trimer level, S, was assumed to be 1
for both liminal and incremental models, because of the existing
support for that assumption (Herrera et al., 2006; Schonning et
al., 1999; Yang et al., 2005a,b). Thus for the incremental pole of
the spectrum, I=p3. This simple incremental model was
compared with liminal models of different total trimer numbers,
n=[5, 9, 15, 45], and all possible thresholds, L, thus, see
Eq. (3).
The parameter a, constrained to 0≤a≤1, was fit by non-
linear regression; a was plotted for values of L yielding R2N0.9.
(In order to explore local minima, in some cases fits were also
based on half-integer values of L.)
ð7ÞBlending of liminal and incremental models at two levels
In order to incorporate the possibility of real and apparent
incremental effects into the liminal framework, coefficients were
introduced such that the thresholds were made gradual. The
blended liminal–incremental models for virions with 9 trimers
are given by Eq. (4) where and IL ¼
P9
r¼ð9Lþ1Þ
9Crqrð1 qÞ9r:
(Eq. (1) with n=9) and the coefficients, c1− 9, give weights to
thresholds of approximate critical numbers of functional trimers
per virion.
Analogously, the putative, absolute protomeric threshold at
the trimer level was softened. This was achieved by allowing
trimer function to take a value between proportionally incre-
mental protomeric effects, at the one extreme, and the
assumption of S=1, at the other. The rationale for this spectrum
is that q=p represents both a protomeric incremental effect and
the average of S=[1, 2, 3], while S=1 is deemed the most
realistic one of the three absolute protomeric thresholds. Thus
q ¼ hpþ ð1 hÞp3 ð8Þ
was incorporated into Eq. (4); the parameter h, constrained to
0≤h≤1, was fit by non-linear regression.
Equations allotting different combinations of weights to the
thresholds were created by letting cL=b
z where the exponent z
of b takes arbitrarily chosen integers ≥0 so as to give peaks at
low, middle and high thresholds. Thereby the breadth of the
threshold peak could also be varied. Three sliding peaks were
explored: consecutive z values within the peak were set to 1, 2, 2,
1; 1, 2, 1 or 1, 2, 3, 2, 1 and all z values outside the peak equal to 0
(giving c=1). Thereby a library of 20 equations allotting
differential weights to different L values in a smooth continuous
manner was created. Finally, the functions were fit by non-linear
regression and the best fits recorded. This always involved the
simultaneous fitting of two parameters: h at the trimer level and
b at the virion level. When all possible coefficients c1− 9
approach 1, the liminal model coalesces with the proportionally
incremental model at the virion level.Non-linear regression and model comparison
Non-linear regressions, based on minimization of the sum of
squares of the distances of the data points from the curve, with
one or two parameters were performed in Prism (Graphpad).
Even in the few exceptional cases where linear regression would
be possible, the non-linear option in Prism was used to fit a first-
order polynomial. There were too few data points to test for the
normality of residuals. Runs tests were performed on all fit
curves and showed no significant deviation from data. Initial
values of fit parameters included b=2, h=0.5 and a=0.5;
similar results were obtained with varied initial values. Themore
complex equations (nN9) were first evaluated in Mathematica
(Wolfram Research) and then transferred to Prism. Since the
rival models have only partly overlapping building blocks and
therefore are not nested in a simple fashion, Akaike's
Information Criterion (Table 3, Burnham and Anderson, 1998;
261P.J. Klasse / Virology 369 (2007) 245–262Herrera et al., 2006), rather than an F test, was chosen for
comparing their fits.
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